Detalhe da pesquisa
1.
Saroglitazar is noninferior to fenofibrate in reducing triglyceride levels in hypertriglyceridemic patients in a randomized clinical trial.
J Lipid Res
; 63(7): 100233, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35605678